Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MBL Venture Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 8
Rounds per year 0.33
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
Summary

MBL Venture Capital is the famous VC, which was founded in 2000. The company was established in Asia in Japan. The main department of described VC is located in the Nagoya.

The standard case for the fund is to invest in rounds with 6 partakers. Despite the MBL Venture Capital, startups are often financed by Morgenthaler Ventures, Advanced Technology Ventures. The meaningful sponsors for the fund in investment in the same round are Shin Nippon Biomedical Laboratories (SNBL), Seraph Group, SR One. In the next rounds fund is usually obtained by SR One, Mitsubishi UFJ Capital, Tohoku University Venture Partners.

Among the various public portfolio startups of the fund, we may underline Second Genome, TMS Co., Ltd., Sentien Biotechnologies We can highlight the next thriving fund investment areas, such as Pharmaceutical, Life Science. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2016.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MBL Venture Capital:
Typical Co-investors
MBL Venture Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MBL Venture Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Japan
Funds with similar focus located in Japan:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerator Technology Holdings Amman, Amman, Jordan
Alphachain Puerto Rico, San Juan, United States
Aston Hill Financial Canada, Ontario, Toronto
Beni VC Florida, Miami, United States
BXR Partners LLP -
China Literature Beijing, Beijing, China
China Urban Realty Association Beijing, Beijing, China
Dragon Ventures China, Hong Kong, Hong Kong Island
Edu-Capital Beijing, Beijing, China
Globivest Beirut, Beyrouth, Lebanon
IN Venture Israel, Tel Aviv, Tel Aviv
Lantianshi Chuangtou Beijing, China, Haidian
METABRIDGE British Columbia, Canada, Vancouver
Naranya Colima, Mexico, Nuevo
Pinnacle Systems California, Mountain View, United States
Royal Enfield Gurgaon, Haryana, India
Sunrise Capital Partners New York, New York, United States
Xing Fu Cheng -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Himuka AM Pharma

Health Care
Medical Device
mHealth
$3M30 Mar 2018 Chiyoda, Japan

Sentien Biotechnologies

Biotechnology
Health Care
Therapeutics
$12M04 Apr 2017 Massachusetts, United States

Second Genome

Biotechnology
Health Diagnostics
Medical
$51M13 Apr 2016 San Francisco, California, United States

Sentieon

Bioinformatics
Biotechnology
Consumer
$3M04 Apr 2014 Mountain View, California, United States

TMS

Biotechnology
Life Science
Pharmaceutical
$330K01 Nov 2011 Fuchu

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MBL Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 10M
Rounds per year 0.33
Peak activity year 2014
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Himuka AM Pharma

Health Care
Medical Device
mHealth
$3M30 Mar 2018 Chiyoda, Japan

Sentien Biotechnologies

Biotechnology
Health Care
Therapeutics
$12M04 Apr 2017 Massachusetts, United States

Second Genome

Biotechnology
Health Diagnostics
Medical
$51M13 Apr 2016 San Francisco, California, United States

Sentieon

Bioinformatics
Biotechnology
Consumer
$3M04 Apr 2014 Mountain View, California, United States

TMS

Biotechnology
Life Science
Pharmaceutical
$330K01 Nov 2011 Fuchu
Crunchbase icon

Content report

The following text will be sent to our editors: